MyRx pharmacogenomic testing is a service initiated by the University of Florida College of Pharmacy and the Center for Pharmacogenomics and Precision Medicine. MyRx was developed with the goal of improving patient outcomes through optimization of efficacy and limiting toxicity of drug therapy.